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Transcriptionane protein (LMP)-2A that functions as a homologue of the activated BCR. We
have previously shown that LMP-2A transactivates a human endogenous retrovirus, HERV-K18, in infected
B-lymphocytes. The Env protein of HERV-K18 encodes a superantigen that strongly stimulates a large
number of T cells. To delineate the mechanism through which LMP-2A transactivates HERV-K18 env, we
tested a panel of tyrosine mutants of LMP-2A in a murine B lymphoma that stably harbors HERV-K18.
Our analysis revealed that the immunoreceptor tyrosine-based activation motif (ITAM) of LMP-2A is
important for HERV-K18 env transactivation. ITAM contains 2 tyrosines that initiate signaling cascades
when both residues are phosphorylated. However, in our study, single-tyrosine mutants of ITAM still
retained full induction of HERV-K18 env. After truncating 25 kb of genomic sequence downstream of
HERV-K18, LMP-2A failed to transactivate HERV-K18 env. Thus, an LMP-2A-inducible element is located
downstream of HERV-K18.
© 2008 Elsevier Inc. All rights reserved.Introduction
The existence of human endogenous retroviruses (HERVs) has
been known for years, but their biological implication has only started
to be realized (Bannert and Kurth, 2004; Nelson et al., 2003). HERV-Ks
make up the youngest and most active family of all HERVs and are
present only in Old World monkeys, apes and humans (Barbulescu et
al., 1999; Turner et al., 2001). HERV-K18, a single-copy provirus in the
HERV-K family, is located in the ﬁrst intron of a cellular gene, cd48, on
the ﬁrst chromosome (1q23.1-q24) (Hasuike et al., 1999; Tonjes et al.,
1999). HERV-K18 and cd48 have the opposite direction of transcrip-
tion, and a NF-κB binding site approximately 1.58 kb upstream of the
cd48 initiation site has been identiﬁed (Klaman and Thorley-Lawson,
1995) (Fig. 1A). Past studies have demonstrated that EBV infection of
B-lymphocytes transactivates HERV-K18, whose Env protein pos-
sesses properties of a superantigen (SAg) (Sutkowski et al., 2001).
SAgs are microbial proteins that greatly over-stimulate the immune
system to elicit a powerful T cell response (Marrack and Kappler,
1990).
Further studies revealed that EBV transactivates the HERV-K18
SAg through latent membrane protein (LMP)-2A, LMP-1, and its).
l rights reserved.cellular receptor, CD21 (Hsiao et al., 2006; Sutkowski et al., 2004).
Among these signaling pathways, LMP-2A provides the most
robust induction. LMP-2A consists of a long cytoplasmic N-terminal
tail, 12 transmembrane domains and a short cytoplasmic C-
terminal tail (Fig. 1C). Its N-terminal tail has 8 tyrosine residues
that are constitutively phosphorylated (Longnecker et al., 1991;
Matskova et al., 2001). LMP-2A's Y112 constitutes part of a YEEA
motif, which mediates the loading of and association with the Src-
family kinase Lyn (Burg et al., 1994; Burkhardt et al., 1991;
Fruehling and Longnecker, 1997; Fruehling et al., 1998). In addition,
LMP-2A's Y74 and Y85 form an immunoreceptor tyrosine-based
activation motif (ITAM), which is found in B, T, and NK cell
receptors (Beauﬁls et al., 1993; Fruehling and Longnecker, 1997;
Gergely et al., 1999). This motif is formed by two tandem repeats
of the conserved sequence, YXXL/I, with a spacer of six to eight
amino acids in between (Cambier, 1995). Phosphorylated Y74 and
Y85 provide a scaffold for the Src Homology 2 (SH2) domain
containing proteins, such as Syk, to interact and subsequently
activate downstream signaling effectors (Fruehling and Longnecker,
1997; Isakov, 1998).
To further delineate the molecular mechanism through which
EBV's LMP-2A transactivates HERV-K18 env, we investigated a panel
of cytoplasmic tyrosine mutants of LMP-2A in a mouse B lymphoma
that harbors HERV-K18. In addition, we mapped genomic sequences
that are important for HERV-K18 env induction by LMP-2A. Our
Fig.1.HERV-K18 and LMP-2A. (A) HERV-K18 is located in the ﬁrst intron of the cellular gene, cd48, at 1q23.1-q24. In relation to cd48, HERV-K18 is on the opposite DNA strand and
has an opposite direction of transcription. At 1.58 kb upstream of the cd48 initiation site, a putative EBV-inducible NF-κB binding site is mapped. (B) Schematic representation of
the full-length and truncated cosmids used to generate the A20-K18F and A20-K18T cell lines, respectively. Candidate enhancers are marked. (C) LMP-2A consists of a long
cytoplasmic N-terminal tail, 12 transmembrane domains and a short cytoplasmic C-terminal tail. The N-terminal tail contains 8 tyrosine residues that are constitutively
phosphorylated. (D) Western blot showing the expression of LMP-2A wt and Y-to-F mutant proteins.
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function of LMP-2A in its induction of HERV-K18 env, suggesting the
existence of a novel ITAM-initiated signaling in our system that is
distinct from the prevailing Lyn–ITAM–Syk axis model (Kurosaki,
1999). In addition, LMP-2A fails to transactivate HERV-K18 env after
a 25 kb truncation of genomic sequence downstream of HERV-K18,
thus implicating this location to contain an inducible element of
HERV-K18.
Results and Discussion
Generation of A20 cells harboring full-length (A20-K18F) and truncated
(A20-K18T) HERV-K18 cosmids
Due to the existence of many HERVs in the human genome, a great
impediment for the study of the HERV-K18 biology lies in assigning
speciﬁcity. Since mice do not have HERVs, creating a HERV-K18 stably
transfected mouse cell line will greatly facilitate the study of HERV-
K18 env transactivation in isolation from other HERVs (Barbulescu et
al., 1999). A20 is a murine B lymphoma cell line that is readily
transfected by electroporation and has been used as an excellent
experimental system to study B cell biology. Furthermore, it was
employed to demonstrate the SAg activity of HERV-K18 Env inprevious studies (Stauffer et al., 2001; Sutkowski et al., 2001). Thus,
A20 is the ideal experimental system for the in vitro study of the LMP-
2A-mediated HERV-K18 env transactivation. A previous report
documented the cloning and isolation of HERV-K18 from a cosmid
library (Hasuike et al., 1999). Cosmid 213, at 45 kb, contains the
full-length HERV-K18. This cosmid was linearized and stably
transfected into A20 to generate the A20-K18F lines. A truncated
cosmid devoid of around 25 kb distal to HERV-K18 was generated
in parallel and stably transfected into A20 to create the A20-K18T
lines (Fig. 1B). In comparison to the full-length cosmid, the
truncated version is missing 13 kb of cd48 upstream regulatory
region, the ﬁrst exon of cd48, as well as a part of the intron that
contains HERV-K18. A putative NF-κB binding site approximately
1.58 kb upstream of the cd48 initiation site has been implicated in
the upregulation of cd48 by EBV in B cells (Klaman and Thorley-
Lawson, 1995). This element may potentially mediate HERV-K18 env
induction by LMP-2A (Fig. 1C). In addition, HERVs' solitary LTRs are
known to contain both promoter and enhancer activities (Casau et
al., 1999; Domansky et al., 2000; Sjottem et al., 1996; Vinogradova
et al., 2001). Thus, the NF-κB binding site and the HERV-K18 LTR
are two candidate enhancers for HERV-K18 SAg induction. Since
A20-K18T does not contain the putative NF-κB binding site,
investigation of the HERV-K18 env transactivation in the two
Fig. 2. Transactivation of IL-2 and HERV-K18 env by LMP-2A. (A, B) ITAM is important for
LMP-2A to transactivate mIL-2 in A20 cells. (A) Real time qRT-PCR was used to assay for
the steady-state mIL-2 transcript. The target transcripts were normalized to the 18S
ribosomal RNA transcripts in the same samples. Four independent experiments were
performed, and a representative experiment is shown here. Error bars are S.E. of
triplicates from a single RT-PCR assay. (B) Culture supernatants were assayed for IL-2
protein using ELISA. Four independent experiments were performed, and a represen-
tative experiment is shown here. Error bars are S.D. of quadruplicates from a single
ELISA assay. (C) Double, but not single, ITAM mutations abolish LMP-2A's ability to
transactivate HERV-K18 env in A20-K18F cells. Four independent experiments were
performed, and a representative experiment is shown here. Error bars are S.E. of
triplicates from a single qRT-PCR assay. EV = empty vector.
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two candidate enhancers.
Both double and single ITAM mutants of LMP-2A fail to transactivate
murine IL-2 in B cells
A20 can be stimulated by Ig crosslinking to produce murine (m)IL-
2, a cytokine that is secreted mostly by T cells (Justement et al., 1989).
Furthermore, the expression of a fusion protein consisting of the
extracellular and transmembrane domains of CD8 and the N-terminal
domain of LMP-2A has been shown to induce mIL-2 transactivation in
A20 cell line upon CD8 crosslinking (Beauﬁls et al., 1993). Therefore,
the transactivation of mIL-2 was utilized as surrogate readout for
LMP-2A signaling in A20 cells. In this study, the LMP-2A wild-type
(wt) cDNA, as well as its N-terminal single and double tyrosine-to-
phenylalanine (Y-to-F) mutants, were transiently transfected into the
A20-K18F cells to dissect the cellular mechanism of HERV-K18 env
transactivation. These point mutants had previously been generated
from site-directed PCR-mediated mutagenesis (Fruehling and Long-
necker, 1997; Fruehling et al., 1998; Swart et al., 1999). The expression
of wt and Y-to-F single and double mutants of LMP-2A in A20 was
veriﬁed with both western-blots and qRT-PCR of LMP-2A transcripts
(Fig. 1D and data not shown). Both assays demonstrated that LMP-2A
mutant and wt cDNAs are expressed robustly in the transfected cells.
The transfection of wt LMP-2A led to a very robust induction of mIL-2
mRNA (Fig. 2A). Since the CD8-LMP-2A fusion protein needed CD8
ligation to induce mIL-2 in A20 cells, our study suggests that the
transfected full-length LMP-2A is constitutively active, likely in
aggregates due to its C-terminal tail (Matskova et al., 2001). In 4
independent qRT-PCR assays, the single (Y74F or Y85F) and double
(Y74/85F) ITAM mutants of LMP-2A consistently failed to transacti-
vate mIL-2 more than the empty vector (EV) control in 24 h (Fig. 2A).
This observation is in accordance with the prevailing model of LMP-
2A signaling, requiring the interaction between Syk and the double-
phosphorylated ITAMs. All other Y-to-F point mutants of LMP-2A
induce mIL-2 very efﬁciently, indicating that they are not critical for
LMP-2A to transactivate this cytokine. Nevertheless, their roles in
mIL-2 induction cannot be ruled out completely. Compensation
between different signaling modules could potentially take place to
mask the effect of single point mutations, particularly in the setting of
LMP-2A over-expression. Surprisingly, the Y112F mutant of LMP-2A
could efﬁciently transactivate mIL-2 in our system. This is in contrast
to the important role that Y112 plays in mediating LMP-2A
phosphorylation and the blockade of BCR signaling (Fruehling et al.,
1998).
To test whether the secreted mIL-2 protein expression correlates
with the distinctive pattern of transcript expression, we collected
culture supernatants from transiently transfected A20 cells and
assayed for IL-2 proteins after 24 h (Fig. 2B). We found a similar
pattern of LMP-2A-induced mIL-2 protein when compared to the
transcript level. In particular, both single and double ITAM mutants
could not induce the A20 cells to secrete mIL-2 protein into the culture
supernatant, whereas the rest of the mutants could, including the
Y112F mutant.
Only the double ITAM mutation can abolish LMP-2A's ability to
transactivate HERV-K18 env in B cells
To investigate the role that phosphotyrosines of LMP-2A play in
HERV-K18 env transactivation, the panel of LMP-2A's single and
double Y-to-F mutants, transiently transfected into the A20-K18F
cells, was used. In 4 independent qRT-PCR assays, the double ITAM
mutant consistently failed to transactivate HERV-K18 env more
than the EV control in 24 h. Surprisingly, single ITAM mutants of
LMP-2A, Y74F and Y85F, could efﬁciently transactivate HERV-K18
env (Fig. 2C). This is in stark contrast to what was observed withthe mIL-2 transactivation in which Y74F and Y85F of LMP-2A were
both non-functional (Figs. 2A and B). Assaying for the relative mIL-
2 transcripts in the same cDNA samples conﬁrmed that Y74F and
Y85F cannot induce mIL-2 in A20-K18F cells (Fig. 2A and data not
shown).
According to the model of BCR and LMP-2A signaling, Syk can only
be activated after it associates with a doubly phosphorylated ITAM
(Kurosaki, 1999). Since the single ITAM mutants of LMP-2A still retain
the full function in HERV-K18 env transactivation, the signaling
mechanism that mediates this transactivation must be distinct from
Fig. 3. A 25 kb region downstream of HERV-K18 is important for HERV-K18 env
transactivation by LMP-2A. A20-K18T and A20-K18F cells were transfected with either
the EV or wt LMP-2A. After 24 h, qRT-PCR was performed on each sample to assay for
the steady-state HERV-K18 env (A) and mIL-2 (B) transcripts. (A) HERV-K18 env cannot
be transactivated by wt LMP-2A in A20-K18T. (B) mIL-2 transcripts were up-regulated
by wt LMP-2A in both A20-K18T and A20-K18F cells. Three independent experiments
were performed, and a representative experiment is shown. The target transcripts were
normalized to the 18S ribosomal RNA transcripts in the same samples. Error bars are S.E.
of triplicates from a single RT-PCR assay.
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2A to transactivate HERV-K18 env, but through a novel mode of
signaling mechanism. Precedence for a single phosphotyrosine
mediated ITAM signaling through Syk has been demonstrated in a
recent drosophila-cell-line reconstitution study (Kurosaki, 1999;
Kurosaki et al., 1995; Rolli et al., 2002). A model has been proposed
based on published experimental data that antigen-stimulated BCR
signaling requires phosphorylation of both ITAM tyrosines, while
weaker tonic signaling requires only a single tyrosine to be
phosphorylated in the ITAM (Monroe, 2006). This model correlates
well with our observation that HERV-K18 env is transactivated in
the range of 10 fold, while IL-2 is in the range of 100–1000 fold.
Interestingly, there is no evidence showing a preferred tyrosine
residue of ITAM in LMP-2A's HERV-K18 env transactivation. Both
single Y74F and Y85F mutants of LMP-2A can transactivate HERV-
K18 env. This is in contrast to the drosophila-cell culture system,
which has a preferred tyrosine residue in ITAM–Syk-mediated tonic
BCR signaling; namely, Lyn is found to preferentially phosphorylate
the proximal tyrosine of ITAM, while Syk can phosphorylate both
(Rolli et al., 2002). This can be explained either by a difference in
the cellular composition between the A20 and the drosophila-cell-
line or an alternative mode of ITAM-mediated signaling with or
without Syk in our system. In fact, a study has shown proper PI-3K,
Ras and MAPK activation after BCR ligation in a Syk−/− cell line. Thus,
BCR signaling can occur independently of Syk (Yokozeki et al.,
2003).
Y112 of LMP-2A constitutes the YEEA motif and has been shown to
be absolutely indispensable for LMP-2A function (Fruehling et al.,
1998). YEEA recruits Src family kinases, such as Lyn, which in turn
facilitates the ITAM-association and activation of Syk. Without Y112,
LMP-2A does not block BCR signaling upon Ig ligation. Surprisingly, in
our system, the Y112F mutant of LMP-2A can efﬁciently transactivate
not only HERV-K18 env, but also mIL-2. Thus, in A20, Y112 is not
important for LMP-2A's signaling outputs. Several explanations can
account for the two different observations. First, we investigated LMP-
2A's function in gene transactivation, while the other study assayed
for LMP-2A's ability to block BCR signaling. Since two different
parameters of LMP-2A's function were tested, the discrepancy may
simply reﬂect differential requirements for the YEEA motif. A study
performed in human epithelial cells supports our observation that the
YEEAmotif is not absolutely important for LMP-2A's signaling through
Syk; namely, the Y112F mutant of LMP-2A could associate with
phosphorylated Syk, presumably through ITAM (Fruehling et al., 1998;
Lu et al., 2006).
Importantly, the induction of HERV-K18 envwas not seen in the EV
controls (Fig. 2C), suggesting that the observed transactivation was
due to the electroporated constructs, but not to contaminants present
in the plasmid preparations. This was an important control, since the
LMP-2A plasmid constructs, puriﬁed from E. coli, may have con-
taminants such as LPS that could activate HERV-K18, although we
have shown previously that LPS cannot transactivate HERV-K18 env
(Sutkowski et al., 2001).
A. 25 kb region downstream of HERV-K18 is important for HERV-K18 env
transactivation by LMP-2A
Since human (h)cd48 is inducible by EBV and LTRs of HERVs have
documented enhancer and promoter activities, we proceeded to
differentiate between the two potential enhancers of HERV-K18 env,
employing the A20-K18T cells. In comparison to the A20-K18F
construct, the A20-K18T construct lacks a 25 kb genomic region that
overlaps with the upstream sequence of hcd48 (Fig. 1C). As such, the
A20-K18F construct carries both potential enhancers, whereas the
A20-K18T construct only has the LTR as single potential enhancer. To
investigate which potential enhancer can mediate HERV-K18 env
transactivation, the wt LMP-2A cDNA was transiently transfectedinto the A20-K18T cell. As shown previously, LMP-2A could
transactivate HERV-K18 env in A20-K18F cells (Fig. 2C). Interestingly,
LMP-2A could not transactivate HERV-K18 env in A20-K18T cells (Fig.
3A). In the same cDNA sample, mIL-2 was transactivated by LMP-2A
(Fig. 3B), thereby serving as a positive control for LMP-2A function.
Thus, this observation suggests that HERV-K18 env is induced by
LMP-2A through a downstream enhancer located in the 25 kb
genomic region that is deleted in the K18T construct. The putative
NF-κB binding site that has been shown to mediate hcd48
upregulation by EBV emerges as the most likely candidate (Klaman
and Thorley-Lawson, 1995). A recent study further corroborates our
observations. In this study, HERV-K18 LTR was placed in a
convergent orientation to a strong transcriptional promoter on the
opposite strand, facing each other, in the exact same arrangement
and direction of transcription as HERV-K18 and hcd48. According to
the model presented in this study, active transcription by RNA
polymerase II from the strong transcriptional promoter on one DNA
strand could displace repressors sitting on HERV-K18 LTR on the
other DNA strand, leading to transcription from HERV-K18 LTR in the
opposite direction (Leupin et al., 2005). This results in coregulated
sense and anti-sense transcripts. As suggested from this model,
active transcription from hcd48 could facilitate HERV-K18 transcrip-
tion by the same mechanism. The model presented in the published
study correlates well with our observation that LMP-2A cannot
transactivate HERV-K18 env in the A20-K18T cell line, but can in the
A20-K18F cell line. This observation also indicates that the LTRs of
HERV-K18 are not inducible by LMP-2A. Since LTRs are known for
their constitutive enhancer and promoter activities, their lack of
functional output in A20-K18T cells suggests the presence of
repressors that actively inhibit HERV-K18 transcription in B cells.
Alternatively, it is possible that the downstream enhancer is
required for the observed activity, but LMP-2A is targeting activation
265F.C. Hsiao et al. / Virology 385 (2009) 261–266through the LTR. Further studies are necessary to distinguish
between these two possibilities.
Materials and methods
Generation of HERV-K18 A20 cell lines
Cosmid clone #213, carrying the full-length HERV-K18, was
obtained from the laboratory of Dr. Hasuike (Asahikawa Medical
College, Japan) (Hasuike et al., 1999). To generate the full-length
HERV-K18 stable A20 cell line (HERV-K18F), the clone #213 was
linearized at a unique site using the restriction enzyme AatII.
Subsequently, the linearized construct was gel-puriﬁed and trans-
fected into A20 cells (ATCC). Clones of stable transfectants were
selected using G418 (Invitrogen) for 1 month to establish the A20-
K18F cell line. To generate the truncated HERV-K18 stable A20 cell line
(HERV-K18T), the cosmid clone #213 was ﬁrst digested with AatII,
followed by a partial digestionwith NotI. The products were run on an
agarose gel, and a correct band corresponding to 18 kb was excised
from the gel. After puriﬁcation, this truncated and linearized construct
was transfected into A20 cells. A20-K18T was selected using G418 to
establish a stable line.
Square-wave electroporation of A20 cells
A20 cells were resuspended at 4×107 cells/ml in pulsing RPMI
media containing 7.5% of Fetal Bovine Serum. Subsequently, A20 cells
(12×106 cells per 300 μl) were mixed with 30 μg of plasmid DNA
construct in a 4 mM gap electroporation cuvette. The cells were left at
rt for 15min before they were subjected to a single pulse from the BTX
ECM 830 square-wave electroporator at 300 V for 10 ms. The cells
were left at rt for an additional 15 min before they were transferred to
complete RPMI media at 37 °C.
LMP-2A tyrosine mutants
The LMP-2A single and double tyrosine-to-phenylalanine (Y-to-F)
mutants were generated in the Longnecker laboratory, using site-
directed PCR-mediated mutagenesis (Fruehling and Longnecker, 1997;
Fruehling et al., 1998; Swart et al., 1999). Both thewt andmutant LMP-
2A cDNA constructs were cloned into the pSG5 vector, downstream of
the SV40 promoter. The pSG5 vector was used as the EV control. The
mutants all had a C-terminal HA-tag.
LMP-2A western blot
A20 cells transfected with LMP-2A were lysed in buffer contain-
ing 1% NP40, 50 mM Tris–HCL (pH 7.4), 150 mM NaCl, 2 mM EDTA,
and a tablet of protease inhibitor cocktail (Roche Applied Science).
After spinning down debris, samples were loaded on a precast gel
(Bio-Rad) and ran for 1 h. The proteins were transferred to a PVDF
membrane (Millipore), using the Trans-Blot SD Semi-Dry Electro-
phoretic Transfer Cell (Bio-Rad). After blocking, the membrane was
incubated with the anti-LMP-2A mAb 14B7 (ITN GmbH, Germany),
and then incubated with an appropriate HRP-secondary Ab. The
PVDF membrane was developed using the ECL Western Blotting
Analysis System (Amersham Pharmacia). Subsequent to ﬁlm
exposure, the membrane was stripped of Abs using Stripping Buffer
(100 mM β-mercaptoethanol, 2% SDS, and 62.5 mM Tris at pH 6.7)
at 55 °C for 30 min. The membrane was then reblotted with anti
β-actin mAbs.
Flow cytometry
Flow cytometry was performed at the Tufts Laser Cytometry core
facility, using the Becton Dickinson FACS-Caliburs. FACS buffer wasmade up of PBS with calcium and magnesium, supplemented with 2%
FBS and 0.09% of sodium azide.
qRT-PCR
Total RNA was isolated using RNeasy Mini Kit (Qiagen). Genomic
DNA contamination was removed using the Turbo DNA-free kit
(Ambion). The cDNA was generated from 1 μg of total RNA using
the iScript reverse transcriptase (BioRad). Duplex qPCR was
performed on the cDNA with the Applied Biosystems Sequence
Detection System 7300, using housekeeping gene 18S ribosomal
RNA (Applied Biosystems) as an internal control and TaqMan PCR
master mix (Applied Biosystems). HERV-K18 TaqMan probe and
primers were designed to recognized HERV-K18 env in A20-K18F
and A20-K18T (Probe: 6-FAM, minor grove binder probe, 5′-TTG
ATC CTT TAG GAA TTT C-3′; forward primer, 5′-CCT AAA GGG AAA
ACT TGC CCC AA-3′; reverse primer; 5′-GCC ACA CAT TCT TCC CAA
ACT AAA A-3′). LMP-2A TaqMan probe and primers were designed
to recognized LMP-2A (Probe: 6-FAM, minor grove binder probe, 5′-
CAG AGG AAG TAT GAA TCC AG-3′; forward primer, 5′-ACT CTC CAC
GGG ATG ACT CAT-3′; reverse primer; 5′-GCA ACA ATT ACA GGC
AGG CAT A-3′). Primers and TaqMan probes for mIL-2 were
purchased from Applied Biosystems through the TaqMan Gene
Expression Assays Services.
Mouse IL-2 ELISA
Wells from Nunc-Immuno Plate (Nunc) were coated with anti-
mIL-2 mAb (BD Biosciences) overnight. Culture supernatants from
LMP-A transfected A20 cells were harvested and incubated in the
wells for 2 h at rt. After 5 washes, biotinylated anti-mIL-2 mAb (BD
Bio-sciences) was added to detect captured mIL-2 proteins. After an
additional 1 h, Alkaline Phosphatase-conjugated NeutrAvidin
(Pierce) was added to the washed wells to interact with the
captured biotinylated anti-mIL-2 mAb. The mIL-2 protein levels
were then estimated from the degree of colorimetric reaction
between the added Immuno-pure PNPP substrate (Pierce) and the
captured Alkaline Phosphatase using a standard spectrometer.
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